divendres, 13 de març del 2015

Bard's Medafor wins injunction against CryoLife's PerClot Topical




A federal judge grants C.R. Bard's Medafor division's bid for an injunction barring U.S. sales of CryoLife's PerClot Topical hemostasis powder.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1NSrMrf

Cap comentari:

Publica un comentari a l'entrada